摘要 |
<p>Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (Ia) and (Ib) where R1, R2, R3, R4, R5, R6, R8, R9 and X aredefined herein. The compoundsare useful for treating autoimmune and other diseases. Also disclosed are processes for making such novel compounds.</p> |